Responses and Survival Are Not Affected by Cytogenetics In Patients with Relapsed and Refractory Multiple Myeloma (R/R MM) Treated with Single-Agent Carfilzomib

被引：0
|
作者：
Jakubowiak, Andrzej J. [1 ]
Martin, Thomas [2 ]
Singhal, Seema B. [3 ]
Wang, Michael
Vij, Ravi [5 ]
Jagannath, Sundar [6 ]
Lonial, Sagar [7 ]
Kukreti, Vishal [8 ]
Buadi, Francis [9 ]
Bray, Lauren [10 ]
Vallone, Marcy [10 ]
Kauffman, Michael [10 ]
Orlowski, Robert Z. [4 ]
Siegel, David Samuel diCapua [11 ]
机构：
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ San Francisco, San Francisco, CA 94117 USA
[3] Northwestern Univ, Feinberg Sch Med, Div Hem Onc, Chicago, IL 60611 USA
[4] Univ Texas Houston, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[5] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[6] Mt Sinai Med Ctr, Myeloma Program, New York, NY 10029 USA
[7] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[8] Princess Margaret Hosp, Div Hematol Oncol, Toronto, ON M4X 1K9, Canada
[9] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA
[10] Onyx Pharmaceut, Emeryville, CA USA
[11] Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[12] Multiple Myeloma Res Consortium, Norwalk, CT USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：809 / 809
页数：1
相关论文
共 50 条
  • [1] RESPONSES TO SINGLE-AGENT CARFILZOMIB (CFZ) ARE NOT AFFECTED BY CYTOGENETICS IN PATIENTS (PTS) WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (R/R MM)
    Jakubowiak, A. J.
    Martin, T.
    Singhal, S.
    Wang, M.
    Vij, R.
    Jagannath, S.
    Lonial, S.
    Kukreti, V.
    Buadi, F.
    Kunkel, L.
    Bray, L.
    Vallone, M.
    Orlowski, R. Z.
    Siegel, D. S.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 122 - 122
  • [2] Influence of Cytogenetics in Patients with Relapsed and Refractory Multiple Myeloma (MM) Treated with Carfilzomib (CFZ).
    Jakubowiak, Andrzej
    Wang, Luhua
    Orlowski, Robert Z.
    Jagannath, Sundar
    Siegel, David
    Stewart, A. Keith
    Kukreti, Vishal
    Lonial, Sagar
    McDonagh, Kevin T.
    Vallone, Marcy
    Kauffman, Michael
    Vij, Ravi
    [J]. BLOOD, 2009, 114 (22) : 725 - 726
  • [3] Management of Hematologic Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib
    Nooka, Ajay K.
    [J]. ONCOLOGY-NEW YORK, 2013, 27 : 11 - 18
  • [4] Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib
    Shah, Jatin J.
    [J]. ONCOLOGY-NEW YORK, 2013, 27 : 19 - 23
  • [5] Overview and Management of Cardiac and Pulmonary Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib
    Wang, Michael
    Cheng, Jie
    [J]. ONCOLOGY-NEW YORK, 2013, 27 : 24 - 30
  • [6] Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
    Harvey, R. Donald
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2014, 6 : 87 - 96
  • [7] Final analysis of MM-014: Single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
    Hussein, M. A.
    Richardson, P. G.
    Jagannath, S.
    Singhal, S.
    Bensinger, W.
    Knight, R.
    Zeldis, J. B.
    Yu, Z.
    Olesnyckyj, M.
    Anderson, K. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Safety profile of single-agent carfilzomib in patients with relapsed or refractory multiple myeloma from 4 phase ll trials
    Siegel, D.
    Martin, T.
    Nooka, A.
    Harvey, R. D.
    Vij, R.
    Niesvizky, R.
    Badros, A. Z.
    Jagannath, S.
    McCulloch, L.
    Rajangam, K.
    Lenial, S.
    [J]. ONKOLOGIE, 2013, 36 : 39 - 40
  • [9] Safety profile of single-agent carfilzomib in patients with relapsed or refractory multiple myeloma from 4 phase 2 trials
    Siegel, D. S.
    Martin, T.
    Nooka, A.
    Harvey, R. D.
    Vij, R.
    Niesvizky, R.
    Badros, A. Z.
    Jagannath, S.
    McCulloch, L.
    Rajangam, K.
    Lonial, S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 20 - 20
  • [10] Single-agent Aredia for relapsed/refractory multiple myeloma.
    Berenson, JR
    Webb, IJ
    Anderson, K
    Schlossman, R
    Vescio, R
    Doss, D
    Goon, B
    Swift, R
    VonTeichert, J
    Kowalski, M
    Seaman, J
    [J]. BLOOD, 1999, 94 (10) : 307B - 307B
12345